GeneDx Holdings Corp. - Warrant — Cash Flow (NASDAQ:WGSWW) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities —-190.43 M-319.15 M-180.15 M-28.5 M33.28 M -9.31 M Cash from investing activities —-20.79 M-141.33 M-43.73 M-30.13 M-61.52 M -69.36 M Cash from financing activities —493.73 M197.31 M186.24 M44.16 M48.02 M 72.9 M Free cash flow —-190.43 M-319.15 M-180.15 M-28.5 M14.26 M -28.65 M

News

GeneDx: Disappointing Q1 Creates Another Turnaround Opportunity (NASDAQ:WGS)

Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine (TEM)

GeneDx: Fundamentals Intact Though Q4 Results Pause Near Term Momentum

GeneDx: A Moment Of Reckoning As Market Awaits Q3 Testing Growth (NASDAQ:WGS)

GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript

GeneDx Holdings Corp. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:WGS)

Macquarie Small Cap Growth Fund Q1 2025 Commentary (WGSWW)

Harbor Health Care ETF Q1 2025 Commentary (undefined:MEDI)

Invesco Health Care Fund Q4 2024 Commentary

GeneDx: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy' (NASDAQ:WGS)

GeneDx Holdings Corp. (WGS) Q4 2024 Earnings Call Transcript